POINT study

Ongoing study

Official Study Title

A non-interventional, Prospective, cross-sectional study Of the INcidence of pulmonary, cardiovascular and renal system non-communicable complications associated with the post-acute phase of the infecTion by SARS-CoV-2

Brief Description

POINT is an innovative research project funded by the European Union with a mission to mitigate the long-term health risks associated with COVID-19. By harnessing advanced biomarkers and a virtual twin model for personalized care, we aim to bridge the gap between scientific discoveries and their practical application in clinical settings. Our goal is to gain a comprehensive understanding of the post-acute phase of COVID-19 and equip healthcare professionals with the necessary tools and guidelines to effectively manage patients.

Details
Status: Recruiting
Study Type: Non-Interventional Study
Study sites: 5 sites in Greece
Target of enrolment: 345 participants

ClinicalTrials.gov Identifier: NCT06608849
Approval from the 1^st Hospital Ethics Committee: 19950 – 01/08/2024-Φ.419 (Thriasio General Hospital of Elefsina)

Study Start: December 2024

Condition/Disease studied: Pulmonary, cardiovascular and renal system non-communicable complications associated with the post-acute phase of the infection by Covid-19.
Keywords: Covid-19; SARS-CoV-2; Pulmonary complications; Cardiovascular complications; Renal complications; Post-acute phase; Non-communicable diseases; Biomarkers; Prevention

Learn more about the European Program HOMI LUNG.